Sabra Health Care
SBRA
Sabra Health Care (SBRA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Equal-Weight | $23.00 from $21.00 | Aug 31, 2026 |
| Baird | Maintained | Neutral | $21.00 from $20.00 | Aug 31, 2026 |
| Raymond James | Upgraded | Underperform → Market Perform | — | Aug 6, 2026 |
| Citizens | Maintained | Market Outperform | $25.00 from $23.00 | Jul 22, 2026 |
| Truist Securities | Maintained | Buy | $24.00 from $22.00 | Jul 22, 2026 |
| Baird | Maintained | Neutral | $23.00 from $22.00 | Jul 22, 2026 |
| Truist Securities | Upgraded | Hold → Buy | $22.00 | Jul 8, 2026 |
| UBS | Maintained | Neutral | $21.00 from $22.00 | Jul 8, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $21.00 | Jul 7, 2026 |
| Citigroup | Downgraded | Buy → Neutral | $19.00 from $24.00 | Jun 23, 2026 |
| Scotiabank | Maintained | Sector Perform | $19.00 from $22.00 | Jun 18, 2026 |
| Raymond James | Maintained | Market Perform → Underperform | — | Jun 17, 2026 |
| Wells Fargo | Maintained | Overweight | $23.00 from $22.00 | Jun 1, 2026 |
| Scotiabank | Maintained | Sector Perform | $22.00 from $21.00 | May 21, 2026 |
| UBS | Maintained | Neutral | $22.00 from $21.00 | May 13, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $22.00 from $21.00 | May 11, 2026 |
| Wells Fargo | Maintained | Overweight | $22.00 from $21.00 | Mar 26, 2026 |
| Truist Securities | Maintained | Hold | $22.00 from $21.00 | Mar 13, 2026 |
| Scotiabank | Maintained | Sector Perform | $21.00 from $20.00 | Mar 2, 2026 |
| UBS | Maintained | Neutral | $21.00 from $20.00 | Feb 19, 2026 |
Frequently asked questions
What is the latest analyst rating on SBRA?
On Aug 31, 2026, Barclays maintained Sabra Health Care at Equal-Weight with a price target of $23.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.